AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
AngioDynamics (ANGO) PT Raised to $13 at Oppenheimer
July 16, 2024 3:27 PM EDTOppenheimer analyst Steven M. Lichtman raised the price target on AngioDynamics (NASDAQ: ANGO) to $13.00 (from $12.00) while maintaining a Outperform rating.
The analyst comments "ANGO's F4Q24 sales of $71.1M (+1.9% y/y pro forma) were in line with the key higher margin/growth... More
